Sign In
Buy DIOD
$116.22
+2.09 (+1.83%)
At Close: Jun 03, 2026
India's Cipla set to undercut rivals with generic remdesivir -sources
12:59pm, Wednesday, 08'th Jul 2020
Indian drugmaker Cipla Ltd has priced its generic version of Remdesivir, Cipremi, at 4,000 rupees ($53.34) per 100 mg vial, according to several sources, making it among the lowest priced versions of
South Korea seeks remdesivir to treat over 5,000 COVID patients -lawmaker
10:18am, Wednesday, 08'th Jul 2020
South Korea has asked Gilead Sciences Inc's to supply enough of its anti-viral drug remdesivir to treat more than 5,000 COVID-19 patients in preparation for a potential second wave of infections, an o
Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the U.S. During COVID-19 Shelter-in-Place Orders
08:01am, Wednesday, 08'th Jul 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced data presented at the 23rd International AIDS Conference (AIDS 2020: Virtual) evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and
State of Tennessee Treasury Department Buys 3,322 Shares of Diodes Incorporated (NASDAQ:DIOD)
09:06am, Sunday, 05'th Jul 2020
State of Tennessee Treasury Department lifted its stake in shares of Diodes Incorporated (NASDAQ:DIOD) by 19.8% during the 1st quarter, according to its most recent 13F filing with the Securities and
Invesco Ltd. Reduces Position in Diodes Incorporated (NASDAQ:DIOD)
07:13am, Saturday, 04'th Jul 2020
Invesco Ltd. lowered its position in shares of Diodes Incorporated (NASDAQ:DIOD) by 37.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exch
After Gilead Reveals Remdesivir Pricing, Analyst Sees Significant Revenue Upside
02:22pm, Thursday, 02'nd Jul 2020
The coronavirus marches on, but healthcare names all over the world are fighting back. Earlier this week, Gilead Sciences (GILD), the manufacturer of COVID-19 antiviral drug remdesivir, revealed the p
Indonesia seeking its own COVID-19 vaccine amid worry about access
11:52am, Thursday, 02'nd Jul 2020
Indonesia is working to produce its own COVID-19 vaccine next year, amid growing anxiety that developing countries could have difficulty getting access to a future jab, the head of Indonesia’s natio
$600 or $3,120? Gilead Puts a Price Tag on Covid-19 Relief
10:30am, Thursday, 02'nd Jul 2020
(Bloomberg Opinion) -- While a world awash in a pandemic awaits a coronavirus vaccine, Gilead Sciences Inc. is bringing a treatment to market.Remdesivir is an experimental drug that may help Covid-19
Global health experts criticize U.S. deal to hog supply of coronavirus drug
10:38pm, Wednesday, 01'st Jul 2020
Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19.
WRAPUP 1-World takes stock of COVID-19 drug remdesivir after U.S. snaps up supplies
05:55pm, Wednesday, 01'st Jul 2020
Some governments in Europe and Asia said on Wednesday they have enough of Gilead's COVID-19 anti-viral remdesivir for now despite fears of shortages since the U.S. drugmaker pledged most output to its
Coronavirus update: U.S. case tally climbs above 2.6 million, and top Republicans now call on Americans to wear face masks
04:10pm, Wednesday, 01'st Jul 2020
The number of confirmed cases of the coronavirus illness COVID-19 in the U.S. climbed above 2.6 million on Wednesday, a day after Dr. Anthony Fauci said it could spike to more than 100,000 a day if th
EU in talks with Gilead to get remdesivir doses for EU countries
04:07pm, Wednesday, 01'st Jul 2020
The European Commission said on Wednesday it was in negotiations with Gilead Sciences Inc to obtain doses of COVID-19 antiviral remdesivir for the 27 European Union countries. The Commission said it
Here’s the latest on what we know works — and doesn’t work — in treating coronavirus infections
03:10pm, Wednesday, 01'st Jul 2020
Steroids and Remdesivir have already been shown to help fight COVID-19. It’s too early to judge on a couple of other possibilities.
UK emergency remdesivir supplies adequate to treat COVID-19, official says
03:09pm, Wednesday, 01'st Jul 2020
Britain has adequate supplies of Gilead's remdesivir for emergency use to treat hospitalised COVID-19 patients, England's deputy chief medical officer said on Wednesday, though he warned of potential
UPDATE: U.S. government to secure majority of Gilead's remdesivir supply through September
01:50pm, Wednesday, 01'st Jul 2020
Health officials said Monday that the U.S. government will receive 500,000 treatment courses of Gilead Sciences Inc.'s remdesivir through September that can then be purchased by American hospitals. T
